Co-Authors
This is a "connection" page, showing publications co-authored by Yimin Li and Nanshan Zhong.
Connection Strength
3.178
-
Secondary infection in severe and critical COVID-19 patients in China: a multicenter retrospective study. Ann Palliat Med. 2021 Aug; 10(8):8557-8570.
Score: 0.240
-
Critical Care Response to the Outbreak of COVID-19: The Experience From Guangdong Province, China. Front Public Health. 2020; 8:576528.
Score: 0.228
-
The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study. BMC Pulm Med. 2020 Nov 09; 20(1):290.
Score: 0.228
-
Clinical Findings of COVID-19 Patients Admitted to Intensive Care Units in Guangdong Province, China: A Multicenter, Retrospective, Observational Study. Front Med (Lausanne). 2020; 7:576457.
Score: 0.227
-
Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J. 2020 08; 56(2).
Score: 0.225
-
Reply by Xu et al. to Haouzi et al. Am J Respir Crit Care Med. 2020 08 15; 202(4):631-632.
Score: 0.224
-
Prone position ventilation support for acute exacerbation of interstitial lung disease? Clin Respir J. 2018 Apr; 12(4):1372-1380.
Score: 0.182
-
Characteristics of Traveler with Middle East Respiratory Syndrome, China, 2015. Emerg Infect Dis. 2015 Dec; 21(12):2278-80.
Score: 0.162
-
[Expression and significance of severe acute respiratory syndrome associated coronavirus (SARS-CoV)-X4 protein in lungs of SARS patients]. Zhonghua Nei Ke Za Zhi. 2006 Mar; 45(3):196-8.
Score: 0.082
-
[Changes in pulmonary function in severe acute respiratory syndrome patients during convalescent period]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005 Jun; 17(6):329-31.
Score: 0.078
-
[Study of laboratory characteristic of 4 patients with sporadic severe acute respiratory syndrome in 2004]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005 Jun; 17(6):332-4.
Score: 0.078
-
[A multicenter prospective cohort study of Xuebijing injection in the treatment of severe coronavirus disease 2019]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jul; 33(7):774-778.
Score: 0.060
-
Earlier diagnosis improves COVID-19 prognosis: a nationwide retrospective cohort analysis. Ann Transl Med. 2021 Jun; 9(11):941.
Score: 0.059
-
Analysis of pathological changes in the epithelium in COVID-19 patient airways. ERJ Open Res. 2021 Apr; 7(2).
Score: 0.059
-
Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients. Genome Med. 2021 02 22; 13(1):30.
Score: 0.058
-
Population Bottlenecks and Intra-host Evolution During Human-to-Human Transmission of SARS-CoV-2. Front Med (Lausanne). 2021; 8:585358.
Score: 0.058
-
COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU. Exp Hematol Oncol. 2021 Feb 01; 10(1):6.
Score: 0.058
-
Addendum: Early triage of critically ill COVID-19 patients using deep learning. Nat Commun. 2021 02 01; 12(1):826.
Score: 0.058
-
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg Microbes Infect. 2020 Dec; 9(1):991-993.
Score: 0.057
-
Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020 10 01; 130(10):5235-5244.
Score: 0.057
-
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020 08 01; 180(8):1081-1089.
Score: 0.056
-
Early triage of critically ill COVID-19 patients using deep learning. Nat Commun. 2020 07 15; 11(1):3543.
Score: 0.056
-
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. 2020 08 06; 182(3):734-743.e5.
Score: 0.055
-
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J. 2020 06; 55(6).
Score: 0.055
-
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 05; 55(5).
Score: 0.055
-
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020 Jul; 146(1):89-100.
Score: 0.055
-
Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study. J Thorac Dis. 2020 May; 12(5):1811-1823.
Score: 0.055
-
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020 07; 158(1):97-105.
Score: 0.055
-
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020 04; 46(4):586-590.
Score: 0.054
-
Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. J Thorac Dis. 2020 Mar; 12(3):165-174.
Score: 0.054
-
High-flow nasal cannula in adults with acute respiratory failure and after extubation: a systematic review and meta-analysis. Respir Res. 2018 Oct 16; 19(1):202.
Score: 0.049
-
Dual effects of human neutrophil peptides in a mouse model of pneumonia and ventilator-induced lung injury. Respir Res. 2018 Sep 29; 19(1):190.
Score: 0.049
-
Distinctive Roles and Mechanisms of Human Neutrophil Peptides in Experimental Sepsis and Acute Respiratory Distress Syndrome. Crit Care Med. 2018 09; 46(9):e921-e927.
Score: 0.049